InvestorsHub Logo
icon url

Whalatane

09/28/22 1:57 PM

#389659 RE: golf stud #389655

Golf. The FDA would require a far larger pivotal trial to show clinically significant risk reduction before approving for Alzheimer’s.
This would require major funding and make AMRN a more serious take over target by a well funded BP
If eventually approved the new indication would have exclusivity for some years

Pt being. A successful BRAVE would drive BP take over interest
Kiwi